TGF-β1 resistance is not associated with alterations in TGF-β type II receptors in immortalized human lung epithelial cells

Cancer Letters

Volumn 113, Issue 1-2, 1997, Pages 65-70

  Hamburger, Anne W ^a,b   Smith, Tamara ^c   Elliget, Kathy ^b   Hagiwara, Koichi ^c   Gerwin, Brenda I ^c  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b Department of Pathology ^*  (United States)

^c Laboratory of Human Carcinogenesis   (United States)

Author keywords

Cancer cells; TGF ; TGF receptors

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; BRONCHUS MUCOSA; CELL CLONE; CELL IMMORTALIZATION; CELL LINE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING; DRUG RESISTANCE; EPITHELIUM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LUNG; METABOLISM;

CELL LINE, TRANSFORMED; DNA, COMPLEMENTARY; DRUG RESISTANCE; EPITHELIUM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUNG; POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031586659     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04596-5     Document Type: Article

References (22)

1. [1] Alexandrow, M.G. and Moses, H.L. (1995) Transforming growth factor β and cell cycle regulation, Cancer Res., 55, 1452-1457.
2. [2] Fynan, T.M. and Reiss, M. (1993) Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis, Crit. Rev. Oncogenesis, 5, 493-540.
3. [3] Hague, A., Manning, H.M., van der Strappen, J.W. and Paraskeva, C. (1993) Escape from negative regulation of growth by transforming growth factor beta and from the induction of apoptosis by the dietary agent sodium butyrate may be important in colorectal carcinogenesis, Cancer Metastasis Rev., 12, 227-237.
4. [4] Wrana, J.L., Attisano, L., Wieser, R., Ventura, F. and Massague, J. (1994) Mechanisms of activation of the TGF-β receptor, Nature, 370, 3341-3347.
5. [5] Park, K., Kim, S.-J., Bang, Y.-J., Park, J.-G., Kim, N.K., Roberts, A.B. and Sporn, M.B. (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β, Proc. Natl. Acad. Sci. USA, 91, 8772-8776.
6. [6] Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Luttgerbaugh, J., Fan, R.S., Aborowska, E., Kinzler, K., Vogelstein, B., Brattain, M. and Willson, J.K.V. (1995) Inactivation of the Type II TGF-β receptor in colon cancer cells with microsatellite instability, Science, 268, 1336-1338.
7. [7] Moustakas, A., Lin, H.Y., Hue, H.F. and Carr, B.I. (1993) Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA, Proc. Natl. Acad. Sci. USA, 90, 5359-5363.
8. [8] Kadin, M.E., Cvaille-Coll, M.W., Gertz, R., Massague, J., Cheifetz, S. and George, D. (1994) Loss of receptor for transforming growth factor β in human T-cell malignancies, Proc. Natl. Acad. Sci. USA, 91, 6002-6006.
9. [9] Reiss, M., Munoz-Antonia, T., Cowan, J.M., Wilkins, P.C., Zhou, Z.-L. and Velluci, V.F. (1993) Resistance of human squamous carcinoma cells to transforming growth factor β1 is a recessive trait, Proc. Natl. Acad. Sci. USA, 90, 6280-6284.
10. [10] MacKay, S.L., Yaswer, L.R., Tarnuzzer, R.W. and Moldawer, L.L. (1995) Colon cancer cells that are not growth inhibited by TGF-β lack functional type I and type II TGF-β receptors, Ann. Surg., 221, 767-777.
11. [11] Winesett, M.P., Ramsey, G.W. and Barnard, G. (1996) Type II TGF beta receptor expression in intestinal cell lines and in the intestinal tract, Carcinogenesis, 17, 989-995.
12. [12] Wieser, R., Attisano, L., Wrana, J.L. and Massague, J. (1993) Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region, Mol. Cell. Biol., 13, 7239-7247.
13. [13] Reddel, R.R., Ke, Y., Gerwin, B.I., McMenamin, M.G., Lechner, J.F., Su, R.T., Brash, D.E., Park, J.-B., Rhim, J.S. and Harris, C.C. (1988) Transformation of human bronchial epithelial cell by infection with SV-40 or adenovirus-SV40 hybrid virus or transfection via strontium phosphate coprecipitation with a plasmid containing SV-40 early regions, Cancer Res., 48, 1904-1909.
14. [14] Ke, Y., Reddel, R.R., Gerwin, B.I., Miyashita, M., McMenamin, M., Lechner, J.F. and Harris, C.C. (1988) Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation, Differentiation, 38, 60-66.
15. [15] Gerwin, B.I., Keski-Oja, J., Seddon, M., Lechner, J.F. and Harris, C.C. (1990) TGF-β1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells, Am. J. Physiol., L259, 262-269.
16. [16] Wrana, J.L., Attisano, L., Carcamo, J., Zentenlla, A., Doody, J., Laiho, M., Wang, X.-F. and Massague, J. (1992) TGFβ signals through a heteromeric protein kinase receptor complex, Cell, 68, 1003-1014.
17. [17] Lin, H.Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R.A. and Hue, H.F. (1992) Expression cloning of the TGF-β Type II receptor, a functional transmembrane serine/threonine kinase, Cell, 68, 775-785.
18. [18] Myeroff, L.L., Parsons, R., Kim, S.-J., Hedrick, L., Cho, K.R., Orth, K., Mathis, M., Kinzler, K.W., Lutterbaugh, J., Park, K., Bang, Y.-J., Lee, H.Y., Park, J.-G., Lynch, H.T., Roberts, A.M., Vogelstein, B. and Markowitz, S.D. (1995) A transforming growth factor β Receptor Type II gene mutations common in colon and gastric but rare in endometrial cancers with microsatellite instability, Cancer. Res., 55, 5545-5547.
19. [19] Zhou, G.-H.K., Sechrist, G.L., Periyasamy, S., Brattain, M.G. and Mulder, K.M. (1995) Transforming growth factor β isoform specific differences in interactions with Type I and II transforming growth factor β receptors, Cancer Res., 55, 2056-2062.
20. [20] Atfi, A., LePage, K., Allard, P., Chapdelaine, A. and Chevalier, S. (1995) Activation of a serine/threonine kinase signaling pathway by transforming growth factor type β, Proc. Natl. Acad. Sci. USA, 92, 12110-12114.
21. [21] Yamaguchi, K., Shirakabe, S., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E. and Matsumoto, K. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-β transduction, Science, 270, 2008-2011.
22. [22] Shiibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E. and Matsumoto, K. (1996) TAB1: An activator of the TAK1 MAPKKK in TGF-β signal transduction, Science, 272, 1179-1182.